Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Other Operating Expenses (2017 - 2025)

Neuronetics (STIM) has disclosed Other Operating Expenses for 9 consecutive years, with $11.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 153.48% to $11.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.0 million, a 139.23% increase, with the full-year FY2024 number at -$75.3 million, down 12.82% from a year prior.
  • Other Operating Expenses was $11.8 million for Q3 2025 at Neuronetics, roughly flat from $11.9 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $13.7 million in Q2 2022 to a low of -$22.2 million in Q3 2024.
  • A 5-year average of $5.0 million and a median of $11.6 million in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: plummeted 282.48% in 2024, then soared 167.78% in 2025.
  • Neuronetics' Other Operating Expenses stood at $10.3 million in 2021, then increased by 16.39% to $12.0 million in 2022, then fell by 2.42% to $11.7 million in 2023, then crashed by 251.31% to -$17.7 million in 2024, then soared by 166.83% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Other Operating Expenses are $11.8 million (Q3 2025), $11.9 million (Q2 2025), and $12.0 million (Q1 2025).